CurrentCardio
Get Weekly

Topic · page 11 of 18

Valvular & structural heart disease

Aortic, mitral and tricuspid disease, TAVI/TEER, surgical valve therapy, PFO/LAA closure

Briefs 401–440 of 696 placed here, newest publication first

Briefs in Valvular & structural heart disease

Newest publication first

  1. JACC Cardiovasc Interv

    Surgical Mitral Valve Repair vs Replacement After Failed Mitral Transcatheter Edge-to-Edge Repair: The CUTTING-EDGE Registry

    Cohort study

  2. JACC Cardiovasc Interv

    Transcatheter Tricuspid Valve Replacement With the Novel System: 1-Year Outcomes From the TRAVEL Study

    Cohort study

  3. J Am Coll Cardiol

    New Threshold for Defining Mild Aortic Stenosis Derived From Velocity-Encoded MRI in 60,000 Individuals

    Cohort study

  4. Eur Heart J

    Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial

    Randomised controlled trial

  5. Lancet

    SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial

    Randomised controlled trial

  6. J Am Coll Cardiol

    Ensemble Deep Learning Algorithm for Structural Heart Disease Screening Using Electrocardiographic Images: PRESENT SHD

    Diagnostic or prognostic study

  7. JACC Cardiovasc Interv

    Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve Replacement: The SwissTAVI Registry

    Cohort study

  8. Europace

    Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society

    Guideline or statement

  9. Circulation

    Cardiac Biomarkers in Patients With Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial

    Secondary analysis

  10. Circulation

    Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial

    Randomised controlled trial

  11. Circulation

    Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial

    Randomised controlled trial

  12. N Engl J Med

    Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation

    Randomised controlled trial

  13. J Am Coll Cardiol

    5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

    Randomised controlled trial

  14. Eur Heart J

    Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-regurgitation study

    Diagnostic or prognostic study

  15. JACC Cardiovasc Imaging

    Machine Learning Identification of Patient Phenoclusters in Aortic Regurgitation

    Cohort study

  16. JACC Cardiovasc Interv

    Early Results of Multicenter Trial of a Novel Balloon-Expandable Valve With Anchor for Aortic Regurgitation

    Cohort study

  17. JACC Cardiovasc Interv

    Initial Experience and Bench Validation of the CLEVE Prosthetic Leaflet Modification Procedure During Aortic and Mitral Valve-in-Valve Procedures

    Diagnostic or prognostic study

  18. Eur J Prev Cardiol

    Prevalence and common cardiovascular risk factors in aortic valve calcification in the middle-aged general population

    Cross-sectional study

  19. JACC Cardiovasc Interv

    Temporal Trends in 1-Year Cause-Specific Mortality After TAVR: Insights From the STS/ACC TVT Registry

    Cohort study

  20. Europace

    Late arrhythmic burden in patients with left bundle branch block after TAVR with the Evolut valve

    Cohort study

  21. J Am Coll Cardiol

    Best Practices for Imaging of Transcatheter Valve Failure: An Update From the Heart Valve Collaboratory

    Guideline or statement

  22. J Am Coll Cardiol

    Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries

    Cohort study

  23. J Am Coll Cardiol

    Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art Review

    Research article

  24. J Am Coll Cardiol

    Transcatheter vs Surgical Aortic Valve Replacement in Lower-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials

    Meta-analysis

  25. J Am Coll Cardiol

    Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk

    Meta-analysis

  26. JACC Cardiovasc Interv

    Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease: 1-Year Results From EXPANDed

    Research article

  27. Eur J Prev Cardiol

    Diabetes and elevated plasma glucose in heart valve calcification and disease: the Copenhagen General Population Study

    Cohort study

  28. JACC Cardiovasc Interv

    Out-of-Hospital 30-Day Mortality After Mitral TEER: Insights From the STS/ACC TVT Registry

    Cohort study

  29. Circulation

    Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy

    Randomised controlled trial

  30. Eur J Heart Fail

    Malnutrition and Outcomes in Patients with Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Repair

    Cohort study

  31. JACC Cardiovasc Interv

    Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis

    Cohort study

  32. Eur J Heart Fail

    Characteristics, Determinants, and Prognostic Impact of Severe Tricuspid Regurgitation in Patients with Atrial Functional Mitral Regurgitation: Insights from the REVEAL-AFMR Registry

    Cohort study

  33. Eur J Prev Cardiol

    Sex differences in cardiovascular–kidney–metabolic risk factors associated with degenerative valvular heart disease

    Cohort study

  34. Eur Heart J

    Baseline characteristics and outcomes of rheumatic mitral valve disease: the EURObservational Research Programme Valvular Heart Disease II Survey

    Cohort study

  35. JACC Cardiovasc Interv

    Tricuspid Regurgitation Disease Stages and Treatment Outcomes After Transcatheter Tricuspid Valve Repair

    Cohort study

  36. JACC Cardiovasc Interv

    Transapical Transcatheter Mitral Valve Replacement After Failed Transcatheter Edge-to-Edge Repair: A Multicenter Experience

    Cohort study

  37. J Am Coll Cardiol

    Long-Term Outcomes of Contemporary Surgical Repair for Degenerative Mitral Regurgitation

    Cohort study

  38. JAMA Cardiol

    Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease

    Research article

  39. JAMA Cardiol

    Outcomes of Balloon-Expandable Transcatheter Aortic Valve Replacement in Younger Patients in the Low-Risk Era

    Cohort study

  40. JAMA Cardiol

    Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation

    Cohort study

All 696 Briefs in ExploreShowing Briefs 401–440 of 696, newest first